Bill 119 hr 307, also known as the Peripheral Artery Disease (PAD) Screening and Education Act, aims to amend titles XVIII and XIX of the Social Security Act to provide coverage for PAD screening tests for at-risk beneficiaries under the Medicare and Medicaid programs. The bill seeks to eliminate cost-sharing requirements for these screening tests, making them more accessible to those who may be at risk for PAD.
Peripheral Artery Disease is a condition that affects the blood vessels outside of the heart and brain, often leading to reduced blood flow to the limbs. Early detection and treatment of PAD can help prevent serious complications such as heart attack, stroke, and limb amputation.
By providing coverage for PAD screening tests without cost-sharing requirements, this bill aims to improve access to preventive care for Medicare and Medicaid beneficiaries who may be at risk for PAD. This could lead to earlier detection and treatment of the disease, ultimately improving health outcomes and reducing healthcare costs in the long run.
In addition to coverage for screening tests, the bill also includes provisions for education and outreach efforts to raise awareness about PAD and the importance of early detection. By increasing awareness and access to screening tests, the hope is to reduce the burden of PAD on individuals and the healthcare system as a whole.
Overall, Bill 119 hr 307 seeks to address an important public health issue by improving access to preventive care for at-risk beneficiaries under Medicare and Medicaid. By providing coverage for PAD screening tests and promoting education and awareness, the bill aims to improve health outcomes and reduce healthcare costs associated with this potentially serious condition.